Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-090197
Filing Date
2025-06-26
Accepted
2025-06-26 08:30:10
Documents
1
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5618
  Complete submission text file 0000950170-25-090197.txt   7164
Mailing Address 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA 22902
Business Address
Manning Paul B (Reporting) CIK: 0001494695 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 251075155

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)